Fu Jimmy Chun-Ming, Wang Nai-Kuang, Cheng Yuan-Yang, Chang Shin-Tsu
Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 407219, Taiwan.
School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.
J Pers Med. 2022 Aug 19;12(8):1333. doi: 10.3390/jpm12081333.
(1) Background: Musculoskeletal pain is both intractable and irritating. Intravenous Laser Irradiation of Blood (ILIB) therapy has been used as pain control treatment for this condition. However, there remains a lack of clear evidence regarding ILIB on pain control. This study aimed to reveal the result of changes in patient pain intensity after receiving ILIB therapy. (2) Methods: We conducted a retrospective analysis of pain scores and sleep quality from 76 patients diagnosed with musculoskeletal disease who received three courses of ILIB therapy. Each course included ten sessions of ILIB treatment over ten consecutive days. During ILIB therapy, patients were inserted with a laser fiber optic needle which irradiated blood cells via a 632.8 nm Helium-Neon laser light over a period of 60 min. Pain scores were evaluated using the Visual Analogue Scale (VAS), whereas sleep quality was assessed by the Pittsburgh Sleep Quality Index (PSQI). These scores would be recorded both before and after each ILIB treatment course. (3) Results: The mean of all patients’ initial VAS score was 5.35. After completing three courses of ILIB treatment, the mean VAS score decreased to 2.2, which indicated a significant reduction in pain intensity. Additionally, patients experienced sleep quality improvement levels from PSQI 8.97 to 5.53 upon completion of three courses of ILIB treatment. (4) Conclusions: Intravenous Laser Irradiation of Blood (ILIB) resulted in a positive pain control effect on patients with musculoskeletal disease, especially for those with moderate to severe pain intensity (initial VAS score >4). Additionally, patients experienced better sleep quality as a result of their pain relief after receiving ILIB treatment.
(1) 背景：肌肉骨骼疼痛既难以治疗又令人烦恼。静脉血激光照射（ILIB）疗法已被用作这种疾病的疼痛控制治疗方法。然而，关于ILIB对疼痛控制的证据仍不明确。本研究旨在揭示接受ILIB治疗后患者疼痛强度的变化结果。(2) 方法：我们对76例被诊断患有肌肉骨骼疾病并接受三个疗程ILIB治疗的患者的疼痛评分和睡眠质量进行了回顾性分析。每个疗程包括连续十天进行十次ILIB治疗。在ILIB治疗期间，通过激光光纤针将患者插入，利用632.8纳米氦氖激光照射血细胞60分钟。使用视觉模拟量表（VAS）评估疼痛评分，而睡眠质量则通过匹兹堡睡眠质量指数（PSQI）进行评估。这些评分将在每个ILIB治疗疗程前后记录。(3) 结果：所有患者的初始VAS评分平均值为5.35。完成三个疗程的ILIB治疗后，VAS评分平均值降至2.2，这表明疼痛强度显著降低。此外，完成三个疗程的ILIB治疗后，患者的睡眠质量改善水平从PSQI 8.97提高到5.53。(4) 结论：静脉血激光照射（ILIB）对肌肉骨骼疾病患者产生了积极的疼痛控制效果，特别是对于那些疼痛强度为中度至重度（初始VAS评分>4）的患者。此外，患者在接受ILIB治疗后因疼痛缓解而睡眠质量更好。
